Literature DB >> 6661736

Mitoxantrone in malignant lymphomas.

R A Gams, J W Keller, H M Golomb, J Steinberg, G Dukart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6661736     DOI： 10.1016/0305-7372(83)90026-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Phase I-II trial of mitoxantrone in acute leukemia: an interim report.

Authors:  Z A Arlin; G Dukart; I Schoch; A Reisman; J Moore; R A Silver; P Cassileth; J Bertino; R Gams
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Human central nervous system and plasma pharmacology of mitoxantrone.

Authors:  R M Green; D J Stewart; H Hugenholtz; M T Richard; M Thibault; V Montpetit
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

3.  High activity of mitoxantrone in previously untreated low-grade lymphomas.

Authors:  S W Hansen; N I Nissen; M M Hansen; K Hou-Jensen; J Pedersen-Bjergaard
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.